Ingevity Corporation

NYSE:NGVT Stock Report

Market Cap: US$2.7b

Ingevity Future Growth

Future criteria checks 3/6

Ingevity is forecast to grow earnings and revenue by 65.7% and 0.9% per annum respectively while EPS is expected to grow by 66.9% per annum.

Key information

65.7%

Earnings growth rate

66.86%

EPS growth rate

Chemicals earnings growth18.2%
Revenue growth rate0.9%
Future return on equityn/a
Analyst coverage

Low

Last updated15 Apr 2026

Recent future growth updates

Recent updates

NGVT: Future P/E Will Reflect Margin Resilience And Impairment Charge Impact

Analysts have increased their price target for Ingevity to $80.50 from $79.25, citing updated assumptions on long term revenue growth, profit margin resilience, and future P/E levels reflected in recent research, including the Wells Fargo target increase. Analyst Commentary Recent research behind the new US$80.50 price target focuses on refreshed assumptions for long term revenue trends, margin resilience, and the P/E level that investors may be willing to ascribe to Ingevity over time.

NGVT: Future P/E Will Depend On Margin Execution And Impairment Fallout

Analysts have raised their price target on Ingevity by $5 to $79.25, citing updated assumptions regarding discount rates, long-term revenue growth, profit margins, and future P/E expectations. Analyst Commentary Analysts raising the price target to $79.25 are updating their models to reflect changes in discount rates, long term revenue assumptions, profit margins, and future P/E expectations.

NGVT: Higher P/E Will Rely On Future Margin Delivery

Analysts have lifted their price target on Ingevity by $5 to $79.25, citing updated assumptions on discount rates, long term revenue growth, profit margins, and future P/E, which support a slightly higher valuation outlook. Analyst Commentary Bullish Takeaways Bullish analysts see the higher price target as consistent with updated assumptions on discount rates and long term revenue growth, which they believe better reflect the company’s current risk profile and earnings potential.

NGVT: Higher P/E Outlook Will Depend On Margin Execution

Analysts have raised their price target on Ingevity by $8.50 to $79.25, citing updated views on revenue growth, profit margins, and an expected higher future P/E multiple. Analyst Commentary Recent Street research has focused on how Ingevity might justify a higher valuation, with specific attention on revenue trends, profitability, and the potential for the shares to support a richer P/E multiple over time.

NGVT: Updated P/E Assumptions And Buybacks Will Shape Balanced Outlook

Analysts have raised their price target on Ingevity by $5 to $70.75, citing updated assumptions around discount rates and future P/E as the main factors behind this revised view. Analyst Commentary Analysts framing the new US$70.75 price target are focusing less on short term headlines and more on what updated discount rate and P/E assumptions imply for Ingevity's risk profile and execution needs.

NGVT: Share Repurchases And Battery Materials License Will Guide Balanced Outlook

Analysts have raised their price target on Ingevity from US$69.50 to US$70.75, citing updated assumptions around discount rates, revenue trends, profit margins and future P/E expectations. Analyst Commentary Analysts who support the higher price target describe it as a fine tuning of their models rather than a wholesale rethink.

NGVT: Buybacks And Battery Materials License Will Shape Balanced Outlook

Analysts have maintained their fair value estimate for Ingevity at US$69.50, with only minor adjustments to inputs such as the discount rate and long-term P/E assumptions. These changes reflect updated modeling rather than a change in conviction.

NGVT: Battery Additives And Buybacks Will Shape Balanced Long-Term Outlook

Analysts have adjusted their price target on Ingevity to US$69.50. This reflects updated views on the discount rate, revenue outlook, profit margins and future P/E assumptions.

NGVT: Future Battery Materials Role Will Drive Long-Term Upside Despite Margin Reset

Analysts have modestly raised their price target on Ingevity by about $1.25 to approximately $69.50. They cite a lower perceived discount rate and an improving revenue trajectory, which more than offset concerns about a structurally lower profit margin and a higher future valuation multiple.

NGVT: Future Battery Materials Role Will Drive Stronger Long Term Upside Potential

Analysts have nudged their price target on Ingevity higher from $65.25 to $68.25, citing a modestly richer future earnings multiple that more than offsets slightly softer revenue growth and margin assumptions. What's in the News Ingevity announced that Executive Vice President and Chief Financial Officer Mary Dean Hall will transition from her role effective May 1, 2026, and remain in an advisory capacity for one year, as part of a planned leadership change.

Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

Sep 30
Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

Does Ingevity (NYSE:NGVT) Have A Healthy Balance Sheet?

Sep 06
Does Ingevity (NYSE:NGVT) Have A Healthy Balance Sheet?

Ingevity: No Specialty Play, Awaiting External Drivers

Sep 05

Portfolio Repositioning And Engineered Additives Will Create A Sustainable Future

Consensus analyst price targets for Ingevity have risen to $65.25, reflecting increased confidence in continued earnings and free cash flow growth following a strong Q2 beat and improved operational outlook. Analyst Commentary Q2 earnings beat, demonstrating stronger-than-expected financial performance.

Portfolio Repositioning And Engineered Additives Will Create A Sustainable Future

The upward revision in Ingevity's revenue growth forecasts from 2.6% to 3.7% per annum has outweighed the impact of a higher discount rate, resulting in an increased consensus analyst price target from $54.25 to $57.00. What's in the News Ingevity Corporation maintained its earnings guidance for 2025, expecting sales between $1.25 billion and $1.40 billion.

Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Jun 27
Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Subdued Growth No Barrier To Ingevity Corporation (NYSE:NGVT) With Shares Advancing 33%

May 28
Subdued Growth No Barrier To Ingevity Corporation (NYSE:NGVT) With Shares Advancing 33%
User avatar

Premium Markets Will Secure Long Term Value

Expansion into premium specialty chemicals and advanced materials is increasing margins and positioning for growth as sustainability trends and vehicle electrification accelerate.

Why We're Not Concerned Yet About Ingevity Corporation's (NYSE:NGVT) 32% Share Price Plunge

Apr 05
Why We're Not Concerned Yet About Ingevity Corporation's (NYSE:NGVT) 32% Share Price Plunge

Ingevity (NYSE:NGVT) Has A Somewhat Strained Balance Sheet

Feb 20
Ingevity (NYSE:NGVT) Has A Somewhat Strained Balance Sheet

Ingevity Corporation (NYSE:NGVT) Shares Could Be 49% Below Their Intrinsic Value Estimate

Jan 16
Ingevity Corporation (NYSE:NGVT) Shares Could Be 49% Below Their Intrinsic Value Estimate

What Ingevity Corporation's (NYSE:NGVT) 32% Share Price Gain Is Not Telling You

Nov 07
What Ingevity Corporation's (NYSE:NGVT) 32% Share Price Gain Is Not Telling You

Is Ingevity (NYSE:NGVT) A Risky Investment?

Oct 13
Is Ingevity (NYSE:NGVT) A Risky Investment?

Ingevity Corporation's (NYSE:NGVT) Prospects Need A Boost To Lift Shares

Sep 08
Ingevity Corporation's (NYSE:NGVT) Prospects Need A Boost To Lift Shares

Ingevity: The Risk-Reward Ratio Is Still Unfavorable

Aug 27

Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 03
Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky

Jul 13
Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky

Should You Investigate Ingevity Corporation (NYSE:NGVT) At US$45.90?

Jun 14
Should You Investigate Ingevity Corporation (NYSE:NGVT) At US$45.90?

Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?

Apr 18
Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?

Is Ingevity (NYSE:NGVT) A Risky Investment?

Mar 22
Is Ingevity (NYSE:NGVT) A Risky Investment?

What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?

Jan 23
What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?

Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares

Jan 04
Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares

These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Nov 10
These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Earnings and Revenue Growth Forecasts

NYSE:NGVT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20281,2072062603283
12/31/20271,1812012473154
12/31/20261,1871662242814
12/31/20251,168-150274331N/A
9/30/20251,382-361240299N/A
6/30/20251,383-354150215N/A
3/31/20251,350-35495166N/A
12/31/20241,200-12151129N/A
9/30/20241,309-25828110N/A
6/30/20241,421-28072169N/A
3/31/20241,640-11287188N/A
12/31/20231,21610695205N/A
9/30/20231,704127128257N/A
6/30/20231,740177120252N/A
3/31/20231,678202154294N/A
12/31/20221,668212171313N/A
9/30/20221,621225160291N/A
6/30/20221,516146171291N/A
3/31/20221,454130152266N/A
12/31/20211,392118190293N/A
9/30/20211,381135273370N/A
6/30/20211,336209272360N/A
3/31/20211,248185264343N/A
12/31/20201,216181270352N/A
9/30/20201,194180199285N/A
6/30/20201,222170222313N/A
3/31/20201,304206238344N/A
12/31/20191,293184161276N/A
9/30/20191,268182N/A276N/A
6/30/20191,219171N/A252N/A
3/31/20191,175161N/A234N/A
12/31/20181,134169N/A252N/A
9/30/20181,085169N/A207N/A
6/30/20181,037153N/A193N/A
3/31/2018989138N/A178N/A
12/31/2017972127N/A174N/A
9/30/201795494N/A187N/A
6/30/201794253N/A144N/A
3/31/201792745N/A131N/A
12/31/201690835N/A128N/A
9/30/201689834N/A111N/A
6/30/201690264N/A100N/A
3/31/201691966N/A92N/A
12/31/201595880N/A72N/A
9/30/201599999N/A76N/A
6/30/20151,025115N/A111N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NGVT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.4%).

Earnings vs Market: NGVT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: NGVT is expected to become profitable in the next 3 years.

Revenue vs Market: NGVT's revenue (0.9% per year) is forecast to grow slower than the US market (11.1% per year).

High Growth Revenue: NGVT's revenue (0.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NGVT's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/03 07:24
End of Day Share Price 2026/05/01 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ingevity Corporation is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Paretosh MisraBerenberg
John McNultyBMO Capital Markets Equity Research
Jonathan TanwantengCJS Securities, Inc.